Abstract
BackgroundBlockade of the programmed cell death protein 1 (PD-1) immune checkpoint (ICB) is revolutionizing cancer therapy, but little is known about the mechanisms governing its expression on CD8 T cells....
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have